Board of Directors

Damon Keeley

Chairman and CEO

In 2013, Damon Keeley founded PRP Concepts™, Inc., in order to provide PRP products and services to clinicians treating chronic, non-healing wounds, and he has since organized the company’s successful research results in order to gain approval to conduct three CMS-sanctioned CED clinical trials to treat diabetic foot, pressure, and venous leg ulcers using the company’s CASCADE® Autologous Platelet System. He was in fact the one who managed the company’s acquisition of the system  from MTF Biologics in February 2021. Damon’s expert professional involvement with the company also serves to illustrate its historical evolution.

Prior to founding the company, Damon founded Autotransfusion Services (ATS) in 1991 to provide autotransfusion and PRP products and services to more than 75 hospitals in New York and New Jersey. In 1997, Damon negotiated the acquisition of Hemo Concepts, a New York corporation providing perfusion services for liver transplants at NYU Medical Center and isolated limb perfusion at Memorial Sloan Kettering. During this all-cash transaction, ATS merged with and changed its name to PRP Concepts, Inc., a New Jersey corporation.

In 1998, just as the AIDS pandemic was peaking, Damon led the company’s effort to become the leader in the field of Bloodless Medicine and Surgery, a strategy that eliminates the need for many donor transfusions. In 1999, Hemo Concepts acquired the Bloodless Medicine and Surgery Institute of Cleveland, Ohio, the only school in the world training physicians and nurses regarding the implementation of these types of programs. Hemo Concepts named its own version of this initiative “Integrated Blood Management” programs.

In 2002, Damon conceptualized, designed, and spearheaded the development of e-BOS, the first internet-based education system to offer online ACCME®-accredited continuing medical education for physicians and nurses seeking to initiate the company’s Integrated Blood Management programs. e-BOS delivered over 25 hours of streaming videos of presentations that were synched to speakers’ written slide presentations and included reference materials along with links allowing users to download original studies and materials. Despite over 25 major medical centers and blood banks in the U.S. and Europe, including Johns Hopkins, Cleveland Clinic, the American Red Cross, and the National Health Service in England, purchasing the company’s Integrated Blood Management program by 2008, the program was ultimately cancelled due to effects of the “Great Recession” of 2007-2009.

Before his immersion in the wellness field, Damon worked from 1984 to 1990 as a licensed securities principal, holding Series 24, Series 7, and Series 63 securities, insurance, and real estate licenses.

ERIC JANIA

EVP of Sales and Marketing for Spartan Medical Inc.

Eric Jania has more than 20 years of experience in product commercialization, business development, key opinion leader (KOL) development, basic science and clinical study design, reimbursement support, marketing, product development, and sales channel creation in the medical device space with a specific focus on biologics. Prior to his current role, Eric was the founder and managing member of E3 Marketing Consultants, LLC, which was started in 2014. E3 provided strategic and executive consulting services for medical device companies in addition to providing sales channel development and commercialization support representing medical device and biologic companies, covering the United States with 150+ sales agents (1099s), a sales manager, and a marketing consultant. Eric has held positions as chief executive officer (CEO) for a small bracing company, executive vice president (EVP) of marketing and new-business development for a small biologic spine company, strategic advisor for two other biologic medical device companies, and marketing consultant for a third company.

Eric spent seven years in the Sports Medicine Division of Electro Biology Incorporated (EBI), a subsidiary of Biomet, and 10 years in the Sports Tissue and Biologics (STB) Division at the Musculoskeletal Transplant Foundation (MTF). The STB Division went to Conmed in 2012 through an asset acquisition when MTF signed a long-term marketing and distribution agreement with Conmed. Eric held a leadership position in that division and was a key member of the due diligence and transition team. In addition, Eric is the acting treasurer of the Patellofemoral Foundation, a not-for-profit 501(c)3 organization that supports education and research for the medical community on patellofemoral disease. He has been a board member of the foundation since 2004. Eric is a graduate of the University of Rhode Island with a BS in marketing and communications.

RICHARD CARROLL

PhD, Chief Scientific Officer

Richard Carroll is the chief scientific officer at PRP Concepts, Inc. Dick has over 40 years’ experience in developing diagnostics and therapeutics. He has been a leader in eight start-up technology companies that have been acquired and has had senior technology management positions in three corporations. Dick has an expertise in blood cell separation and has developed technologies that have allowed progress in molecular diagnostics and regenerative medicine, with six patent filings and numerous publications. He has organized and led several key clinical studies and has been part of seven FDA 510(k) clearances. Dick also been VP, business development, for several companies, connecting technologies and opportunities for greater success. Dick has a BS (in biology) and a PhD (in immunology and microbiology) from SUNY Upstate Medical University.